Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
05/2003
05/22/2003CA2461481A1 Ptp1b inhibitors and ligands
05/22/2003CA2460959A1 Enzymes
05/21/2003EP1312920A1 Method of screening remedy for heart failure
05/21/2003EP1312612A1 Cyclic peptide derivative
05/21/2003EP1312609A1 Boronic ester and acid compounds, synthesis and uses
05/21/2003EP1312379A1 Fibrinogen lowering agents
05/21/2003EP1312374A1 Sugar absorption inhibitors and process for producing the same
05/21/2003EP1312373A1 Antiallergic agents, drugs, foods, drinks or cosmetics containing them and process for producing the same
05/21/2003EP1312372A1 Cytokine production inhibitors, agents for protecting and promoting liver function, anti-inflammatory agents, immunosuppressants, drugs, cosmetics, foods and food materials
05/21/2003EP1312364A1 Cytokine production inhibitors
05/21/2003EP1312363A1 Methods of treatment and kits comprising a growth hormone secretagogue
05/21/2003EP1312362A1 Method for the suppression of visceral pain by regulating T-type calcium channel
05/21/2003EP1312359A2 Use for 1,3-propanediol compounds
05/21/2003EP1311708A1 Method for identifying substances useful for treating inflammation using the response element to the ikappabaplha ror receptor
05/21/2003EP1311699A2 Adeno-associated virus-mediated delivery of angiogenic factors
05/21/2003EP1311684A1 Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them
05/21/2003EP1311678A2 Cripto tumour polypeptide
05/21/2003EP1311677A2 Regulation of human p2y1-like g protein-coupled receptor
05/21/2003EP1311674A2 Compositions and methods for the diagnosis and treatment of tumor
05/21/2003EP1311672A1 New sequences
05/21/2003EP1311664A2 Microtubule-associated proteins and tubulins
05/21/2003EP1311663A2 Claudin polypeptides
05/21/2003EP1311660A1 METHOD OF SCREENING FOR INHIBITORS OF HUMAN FATTY ACID-CoA LIGASE 4
05/21/2003EP1311547A2 Diagnosis and treatment of cardiovascular conditions
05/21/2003EP1311543A1 T cell receptor v beta-d beta-j beta sequence and methods for its detection
05/21/2003EP1311539A2 Pro-apoptotic fragments of the dengue virus envelope glycoproteins
05/21/2003EP1311534A1 Thioether-sulphamate steroids as steroid sulphatase inhibitors and anti-cancer compounds
05/21/2003EP1311533A1 17-aryl-linker derivatised estrogen 3-sulphamates as inhibitors of steroid sulphatase
05/21/2003EP1311532A1 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase
05/21/2003EP1311531A1 Steroid derived antibiotics
05/21/2003EP1311525A2 Composition and method for inhibiting platelet aggregation
05/21/2003EP1311511A1 Pyrazole compounds, pharmaceutical compositions, and methods for modulating or inhibiting erab or hadh2 activity
05/21/2003EP1311508A2 Novel beta-amyloid inhibitors, method for producing the same and the use thereof as medicaments
05/21/2003EP1311507A1 Fused pyrazole derivatives being protein kinase inhibitors
05/21/2003EP1311505A2 Quinuclidine-substituted heteroaryl moieties for treatment of disease ( nicotinic acetylcholine receptor ligands )
05/21/2003EP1311503A1 Chromenone derivatives and their use for treating diseases in conjunction with 5-hta1 receptors and/or dopamine d2 receptors
05/21/2003EP1311500A2 Indole, azaindole and indazole derivatives having vegf inhibiting activity
05/21/2003EP1311498A1 Diamino phenothiazine derivatives and composition comprising same
05/21/2003EP1311489A1 Biphenyl derivatives and the use thereof as integrin inhibitors
05/21/2003EP1311488A1 Substituted imidazoles as tafia inhibitors
05/21/2003EP1311484A1 Biphenyl derivatives and the use thereof as integrin inhibitors
05/21/2003EP1311482A2 Non-imidazole aryloxypiperidines as h3 receptor ligands
05/21/2003EP1311480A1 New amidino derivatives and their use as thrombin inhibitors
05/21/2003EP1311474A1 Sulfonamide derivatives
05/21/2003EP1311302A2 Pharmaceuticals for the imaging of angiogenic disorders
05/21/2003EP1311298A2 System for regulating in vivo the expression of a transgene by conditional inhibition
05/21/2003EP1311297A1 A method for reducing stress-induced overproduction of neuropeptide y in an individual
05/21/2003EP1311295A2 Use of 5ht4 receptor antagonists in the manufacture of a medicament for the prophylaxis or treatment of atrial fibrillation
05/21/2003EP1311293A2 Combinations of ssri and estrogenic agents
05/21/2003EP1311291A2 Treatment of hyperproliferative diseases with epidermal growth factor receptor antagonists
05/21/2003EP1311290A2 Expression of herstatin, an alternative her-2/neu product, in cells that express either p185her-2 or the egf receptor inhibits receptor activity and cell growth
05/21/2003EP1311273A2 Combination of a purine and an nsaid for treating sexual dysfunction
05/21/2003EP1311269A2 Method of using diketopiperazines and composition containing them
05/21/2003EP1311267A1 A retroviral immunotherapy
05/21/2003EP1311265A2 Pharmaceutical compositions for treating neurological disorders
05/21/2003EP1311264A1 Substituted and non-substituted benzooxathiazoles and compounds derived therefrom
05/21/2003EP1311263A2 Fused pyrrolocarbazoles against inflammation
05/21/2003EP1311262A1 Cancer treatment by combination therapy
05/21/2003EP1311261A1 Medicaments for chemotherapeutic treatment of disease
05/21/2003EP1311260A2 Lipase inhibitors to treat dyspepsia
05/21/2003EP1311259A2 Pharmaceutical composition comprising a photochemotherapeutic agent and a mucoadhesive agent
05/21/2003EP1311255A1 Compounds having mif antagonist activity
05/21/2003EP1311253A2 Use of vitamin d derivatives as bone resorption inhibitors
05/21/2003EP1311252A2 Treatment of wounds
05/21/2003EP1311251A2 Use of dopamine d2/d3 receptor agonists to treat fibromyalgia
05/21/2003EP1311249A1 Transdermal therapeutic system
05/21/2003EP1311248A1 Transdermal therapeutic system for treating restless-legs-syndrome
05/21/2003EP1204675B1 Streptogramin derivatives, production thereof and compositions containing the same
05/21/2003EP1192450A4 High energy phototherapeutic agents
05/21/2003EP1189585B1 Cosmetic skin care compositions containing cumic alcohol
05/21/2003EP1147114B1 Novel aralkyl amines of spirofuropyridines useful in therapy
05/21/2003EP1144003A4 Methods and devices for delivery of agents to breast milk ducts
05/21/2003EP1131334A4 Use of core 2 glcnac transferase inhibitors in treating inflammation
05/21/2003EP1129096B1 Crf receptor antagonists and methods relating thereto
05/21/2003EP1047668B1 Triazepinones, process for their preparation and their therapeutic application
05/21/2003EP1023268B1 Isoquinolines as urokinase inhibitors
05/21/2003EP1009732B1 1-amino-alkylcyclohexane nmda receptor antagonists
05/21/2003EP0993303B1 Substances in order to achieve preference and create acceptance
05/21/2003EP0991616B1 METHOD FOR PRODUCING MEDICAMENTS CONTAINING HMG-CoA-REDUCTASE INHIBITORS
05/21/2003EP0964863B1 Oxazolidines as 5-ht2a-antagonists
05/21/2003EP0874818B1 Novel substituted aryl compounds useful as modulators of acetylcholine receptors
05/21/2003EP0851855B9 Acylated derivatives of melatonin and its analogues, useful as medicaments
05/21/2003EP0845939B1 Lysosomal proteins produced in the milk of nonhuman transgenic animals
05/21/2003EP0837699B1 Immunovectors for the intracellular and intranuclear transport
05/21/2003CN1419565A Chimeric Prostate-homing peptides with pro-apoptotic activity
05/21/2003CN1419560A Anti-infective actatm
05/21/2003CN1419559A Tricyclic protein kinase inhibitors
05/21/2003CN1419554A Process for preparing crystalline form 1 of cabergoline
05/21/2003CN1419553A Prodigiosin-derivatives as neoplastic and anti-viral agents
05/21/2003CN1419552A 2-amino-3-(alkyl)-pyrimidone derivatives as GSKS beta. inhibitors
05/21/2003CN1419548A 4-amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhbitors of cell-cycle kinases
05/21/2003CN1419547A Compounds exhibiting thrombopoietin receptor agaonism
05/21/2003CN1419546A 4,5-dihydro-1h-pyrazole derivatives having cbi-antagonistic activity
05/21/2003CN1419545A 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
05/21/2003CN1419541A Pharmaceutically active pyrrolidine derivatives as BAX inhibitors
05/21/2003CN1419539A Amidino compound and salts thereof useful as nitric oxide synahase inhibitors
05/21/2003CN1419534A Diphenyl ether compounds useful in therapie
05/21/2003CN1419532A Novel fatty acid analogous
05/21/2003CN1419455A Physiologically active compositions of basidiomycotina and araliaceae extracts
05/21/2003CN1419452A Synergistic methods and compositions for treating cancer
1 ... 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 ... 1564